Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

869 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation.
Sánchez-Lázaro IJ, Almenar L, Martínez-Dolz L, Buendía-Fuentes F, Agüero J, Navarro-Manchón J, Vicente JL, Salvador A. Sánchez-Lázaro IJ, et al. Among authors: salvador a. Clin Transplant. 2011 Jul-Aug;25(4):606-13. doi: 10.1111/j.1399-0012.2010.01309.x. Epub 2010 Jul 28. Clin Transplant. 2011. PMID: 20682020 Clinical Trial.
Does multiorgan donation influence survival in heart transplantation?
Almenar-Pertejo M, Almenar L, Martínez-Dolz L, Campos J, Galán J, Gironés P, Salvador A. Almenar-Pertejo M, et al. Among authors: salvador a. Transplant Proc. 2006 Oct;38(8):2527-8. doi: 10.1016/j.transproceed.2006.08.020. Transplant Proc. 2006. PMID: 17097989
Study of the evolution of the clinical profile of heart donors.
Almenar-Pertejo M, Almenar L, Martínez-Dolz L, Campos J, Galán J, Gironés P, Salvador A. Almenar-Pertejo M, et al. Among authors: salvador a. Transplant Proc. 2006 Oct;38(8):2529-30. doi: 10.1016/j.transproceed.2006.08.021. Transplant Proc. 2006. PMID: 17097990
Does amiodarone influence early mortality in heart transplantation?
Sánchez-Lázaro IJ, Almenar L, Martinez-Dolz L, Chamorro C, Moro J, Agüero J, Rueda J, Zorio E, Arnau MA, Salvador A. Sánchez-Lázaro IJ, et al. Among authors: salvador a. Transplant Proc. 2006 Oct;38(8):2537-8. doi: 10.1016/j.transproceed.2006.08.022. Transplant Proc. 2006. PMID: 17097993 Clinical Trial.
Induction therapy with daclizumab in heart transplantation--how many doses?
Ortiz V, Almenar L, Martínez-Dolz L, Zorio E, Chamorro C, Moro J, Agüero J, Rueda J, Arnau MA, Salvador A. Ortiz V, et al. Among authors: salvador a. Transplant Proc. 2006 Oct;38(8):2541-3. doi: 10.1016/j.transproceed.2006.08.024. Transplant Proc. 2006. PMID: 17097995 Clinical Trial.
Influence of immunosuppression regimen on heart transplantation survival.
Agüero J, Almenar L, Martínez-Dolz L, Chamorro C, Moro J, Rueda J, Arnau MA, Zorio E, Izquierdo M, Salvador A. Agüero J, et al. Among authors: salvador a. Transplant Proc. 2006 Oct;38(8):2550-2. doi: 10.1016/j.transproceed.2006.08.080. Transplant Proc. 2006. PMID: 17097998
869 results